Skip to main content

Part of UT Health San Antonio

Profiles - UT Health San AntonioProfiles - UT Health Science Center San Antonio

Part of UT Health San Antonio

Menu
  • Home

You are here

  • Profiles Home
  • Faculty Directory
  • Freytes, Cesar O
photo not available

Contact

210-617-5268

freytes@uthscsa.edu

Departments & Divisions

  • Department of Medicine

Cesar O Freytes

  • Professional Background

    Education

    • 1985 - Clinical Fellowship - Hematology/Oncology - Washington University
    • 1981 - Residency - Medicine - San Juan VAMC, PR
    • 1979 - Internship - Medicine - San Juan VAMC, PR
    • 1979 - MD - Internal Medicine - University of Puerto Rico School of Medicine
    • 1976 - BS - Biology - University of Puerto Rico

    Appointments

    • 9/2004 - Professor and Director: Adult Hematopoeitic Stem Cell Transplant Program - UTHSCSA, Medicine, San Antonio
    • 11/1991 - Staff Physician - Cancer Therapy and Research Center, Medicine, San Antonio
    • 11/1991 - Consultant - Southwest Texas Methodist, Medicine, San Antonio
    • 11/1991 - Staff Physician - ALMMVH, Medicine, San Antonio
    • 11/1991 - Staff Physician - University Hospital, Medicine, San Antonio
  • Instruction & Training

    • - Present, Individual Instruction, VA Hospital and UTHSCSA
    • 10/2010 - Present, Fellow Lecture, UTHSCSA
    • 9/2007 - Present, Medicine Grand Rounds, UTHSCSA
    • 9/2007 - Present, Housestaff Conference, UTHSCSA
    • 1/2004 - Present, Outpatient Bone Marrow Transplant, UTHSCSA
    • 9/2000 - Present, Housestaff Conference, UTHSCSA
    • 8/2000 - Present, Housestaff conference, UTHSCSA
    • 8/2000 - Present, Housestaff conference, UTHSCSA
    • 5/2000 - Present, Housestaff conference, UTHSCSA
    • 3/2000 - Present, Housestaff conference, UTHSCSA
    • 1/2000 - Present, Hematology Service, UTHSCSA
    • 1/2000 - Present, Hematology clinic, UTHSCSA
    • 1/2000 - Present, Hematology Service, UTHSCSA
    • 1/2000 - Present, Outpatient BMT, UTHSCSA
    • 1/2000 - Present, Hematology clinic, UTHSCSA
    • 12/1999 - Present, Intro to Clin Medicine, The University of Texas Health Science Center
    • 12/1999 - Present, Intro to Clin Medicine, The University of Texas Health Science Center
    • 11/1999 - Present, Intro to Clin Medicine, The University of Texas Health Science Center
    • 5/1999 - Present, Oncology Research Conference, UTHSCSA
    • 3/1999 - Present, Housestaff Conference, UTHSCSA
    • 2/1999 - Present, Intro to Clinical Medicine, The University of Texas Health Science Center
    • 2/1999 - Present, Intro to Clinical Medicine, The University of Texas Health Science Center
    • 1/1999 - Present, Hematology clinic, UTHSCSA
    • 1/1999 - Present, Hematology service, UTHSCSA
  • Research & Grants

    Grants

    Private

    Funding Agency
    Otsuka Pharmaceutical

    Title
    A Multi-enter, Phase 2, Single-Arm, open-label exploratory study of individually-optimized conditioning using pharmacokinetics (PK)-direct dose adjustment of once daily intravenous busulfan. Followed by autologous hematopoietic stem cell transplant in su

    Status
    Active

    Period
    9/2009 - Present

    Role
    Principal Investigator

    Grant Detail
     

    Funding Agency
    FlaxoSmithKline

    Title
    Ofatumumab versus Rituximab Salvage Chemoimmunotherapy followed by ASCT in relapsed or refractory DLBCL

    Status
    Active

    Period
    11/2009 - Present

    Role
    Co-Investigator

    Grant Detail
     

    Funding Agency
    Otsuka Pharmaceutical

    Title
    A Phase 2a study of once daily intravenous busulfan with bortezomib. Followed by an autologous hematopoietic stem cell transplant (HSCT) in subjects with relapsed multiple myeloma after prior autologous HSCT

    Status
    Active

    Period
    4/2010 - Present

    Role
    Co-Investigator

    Grant Detail
     

    Funding Agency
    Kabi-Pharmacia

    Title
    A Randomized Phase III Double-Blind Study of the Use of Linomide vs. Placebo Following Autologous Bone Marrow Transplantation for the First or Subsequent Remission Complete Remission in Acute Myelogenous Leukemia

    Status
    Active

    Period
    11/1993 - Present

    Role
    Principal Investigator

    Grant Detail
     

    Funding Agency
    Independent research

    Title
    A multicenter phase II study of rituximab in patients with CD20 positive intermediate-grade and select high-grade non-hodgkin's lymphoma who have relapsed after high-dose chemotherapy and autologous stem cell transplantation.

    Status
    Active

    Period
    5/2000 - Present

    Role
    Co-Investigator

    Grant Detail
    A multicenter phase II study of rituximab in patients with CD20 positive intermediate-grade and select high grade non-Hodgkin's lymphoma who have relapsed after high-dose chemotherapy and autologous stem cell transplantation.

    Funding Agency
    CellPro, Inc.

    Title
    A Prospective Randomized Phase III Study Using CEPRATE SC Stem Cell Concentrator to Concentrate Hematopoietic Progenitors for Use in hematopoietic Support After High Dose Chemotherapy

    Status
    Active

    Period
    7/1992 - Present

    Role
    Principal Investigator

    Grant Detail
     

     

    Funding Agency
    Human Genome Sciences

    Title
    A multicenter, rising-dose, randomized double-blinded study vehicle controlled study of intravenous KGF-2 in subjects at risk of developing mucositis secondary to the action of conditioning regimens for autologous hematopoietic stem cell transplantation.

    Status
    Active

    Period
    3/2000 - Present

    Role
    Principal Investigator

    Grant Detail
    A multicenter, rising-dose, randomized double-blinded study vehicle controlled study of intravenous KGF-2 in subjects at risk of developing mucositis secondary to the action of conditioning regimens for autologous hematopoietic stem cell transplantation.

map image

UT Health San Antonio

7703 Floyd Curl Drive
San Antonio, TX 78229

210-567-7000

We make lives better ©

We're a part of UT Health San Antonio, provider of comprehensive health,  dental, &  cancer care,  advanced academics,  and  life-saving research.

Web Privacy | Links from websites affiliated with The University of Texas Health Science Center at San Antonio's website (uthscsa.edu) to other websites do not constitute or imply university endorsement of those sites, their content, or products and services associated with those sites. The content on this website is intended to be used for informational purposes only. Health information on this site is not meant to be used to diagnose or treat conditions. Consult a health care provider if you are in need of treatment.